Basis of Presentation and Other Information (Tables)

6 Months Ended

Jun. 30, 2026

Basis of Presentation and Other Information [Abstract]

Schedule of Basic and Diluted Net Loss Per Share

The following tables present the weighted-average common shares used in the computation of basic and diluted net loss per share for the three and six months ended June 30, 2026 and 2025, and the potentially dilutive securities excluded from the computation of diluted net loss per share because their inclusion would have been anti-dilutive.

		For the Three Months Ending June 30,								For the Six Months Ending June 30,
		2026				2025				2026				2025
Weighted-average common shares outstanding used in calculating basic earnings per share			10,790,722				4,823,125				9,230,710				4,823,125
Effect of dilutive securities			-				-				-				-
Weighted average common shares used in calculating diluted earnings per share			10,790,722				4,823,125				9,230,710				4,823,125

Schedule of Dilutive Securities Diluted Net Loss Per Share

Because the Company incurred a net loss for each period presented, all potentially dilutive securities were excluded from the computation of diluted net loss per share because their effect was anti-dilutive.

		For the Three Months Ending June 30,								For the Six Months Ending June 30,
		2026				2025				2026				2025
Because the Company incurred a net loss, the following potentially dilutive securities would be anti-dilutive and therefore are excluded from the computation of diluted EPS:
Warrants to purchase Common Stock			3,656,172				15,096				3,656,172				15,096
Options to purchase Common Stock			3,572,796				2,979,860				3,572,796				2,979,860
Series E Preferred Stock			11,743,000				-				11,743,000				-
Series D Preferred Stock			-				101,565				-				101,565
Series C Preferred Stock			-				1,204,040				-				1,204,040
Series B Preferred Stock			-				1,471,487				-				1,471,487
Series A-2 Preferred Stock			-				442,402				-				442,402
Series A-1 Preferred Stock			-				651,465				-				651,465
Series A Preferred Stock			-				846,368				-				846,368

Total potential common shares excluded			18,971,968				7,712,283				18,971,968				7,712,283